EU ingredient rules · 1 min read

Lanolinamide DEA in cosmetics: EU rules

Quick answer: Lanolinamide DEA is a restricted cosmetic ingredient in the EU: Annex III (entry 60) allows it only within set limits. CosIng lists its functions as emulsifier, emulsion stabilising, cleansing surfactant and viscosity controlling.

Key facts

Lanolinamide DEA at a glance
INCI nameLANOLINAMIDE DEA
CAS number85408-88-4
EC number287-051-4
EU statusRestricted (Annex III, entry 60)
Functions (CosIng)Emulsifier, Emulsion stabilising, Cleansing surfactant, Viscosity controlling

CosIng description: Fatty acids, lanolin, compds. with diethanolamine

What it does in a product

  • Emulsifier: Lets oil and water blend into a cream or lotion.
  • Emulsion stabilising: Helps keep the oil and water in a cream or lotion from separating.
  • Cleansing surfactant: Washes away dirt and oil.
  • Viscosity controlling: Thickens or thins a product.

Annex III: restricted substances, entry 60

Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.

The entry is listed as Fatty acid dialkylamides and dialkanolamides

Maximum concentration in the ready-to-use product:

Other conditions:

Most recent legal act listed by CosIng for this entry: Regulation (EC) 2009/1223.

Scientific Committee on Consumer Safety (SCCS) opinions:

Why it matters for shelf life

The EU rules above cover what may go into a product, not how long it lasts. For that, follow the period after opening (the open-jar symbol) or the date printed on the pack, and stop using anything that has changed in smell, color or texture.

Not sure how to read a label? What an INCI name is · How ingredient lists work

Source

European Commission, CosIng (Cosmetic Ingredients database), entries for LANOLINAMIDE DEA and Annex III/60, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.